A Service For Professionals Saturday, October 21, 2017
Contact (202) 540-8337
Consumer News Today
A Service For Professionals Saturday, October 21, 2017 11614 Sources 411,092,925 Articles 3,134,516 Readers
Contact (202) 540-8337

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Avinger, Inc. and Reminds Investors with Losses to Contact the Firm

/EIN News/ -- LOS ANGELES, Aug. 11, 2017 (GLOBE NEWSWIRE) -- Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Avinger, Inc. (“Avinger” or the “Company”) (Nasdaq:AVGR) for possible violations of federal securities laws. Investors who purchased or otherwise acquired Avinger shares pursuant and/or traceable to its initial public offering (“IPO”) on January 30, 2015, should contact the firm prior to the September 5, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the Complaint, the Registration Statement and Prospectus filed for Avinger’s IPO contained materially false and misleading statements and/or failed to disclose: that the Company did not have adequate sales and marketing personnel to increase sales of its lumivascular platform products and to commercialize Pantheris; that Avinger already experienced problems with the robustness of its lumivascular platform devices, including Pantheris; that physicians and hospitals were requiring more extensive and comprehensive training and education on the benefits of Avinger’s products to convince them to adopt and implement its lumivascular platform products instead of competing products and procedures available in the market; that the Company would not be able to achieve a rapid ramp rate for increased sales of its lumivascular platform; and that as a result of the above, Avinger was experiencing lower sales and revenues. Following this news, the Company’s shares fell in value, causing investors harm according to the Complaint.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding the rights of shareholders.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethics rules.

Contact:
                    Lundin Law PC
                    Brian Lundin, Esq.
                    Telephone: 888-713-1033
                    Facsimile: 888-713-1125
                    brian@lundinlawpc.com
                    http://lundinlawpc.com/

Primary Logo

Powered by EIN News
Distribution channels: Consumer Goods, Law
Submit your press release